677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia

Obstetrics and Gynecology

Volumn 96, Issue 2, 2000, Pages 277-280

  Laivuori, Hannele ^a   Kaaja, Risto ^a   Ylikorkala, Olavi ^a   Hiltunen, Timo ^a   Kontula, Kimmo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); RESTRICTION ENDONUCLEASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE; PRIMER DNA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; ALLELE; AMINO ACID SUBSTITUTION; CASE CONTROL STUDY; ENZYMOLOGY; FINLAND; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; PREGNANCY;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; FINLAND; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 0033623927     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00896-6     Document Type: Article

References (19)

1. Stampfer M., Malinow M., Willett W. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
2. Arnesen E., Refsum H., Bonaa K., Ueland P., Forde O., Nordrehaug J. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:1995;704-709.
3. Kang S., Zhou J., Wong P., Kowalisyn J., Stroksch G. Intermediate homocysteinemia A thermolabile variant of methylenetetrahydrofolate reductase . Am J Hum Genet. 43:1988;414-421.
4. Frosst P., Blom H., Milos R., Goyette P., Sheppard C., Matthews R., et al. A candidate genetic risk factor for vascular disease A common mutation in methylenetetrahydrofolate reductase . Nat Genet. 10:1995;111-113.
5. Rajkovic A., Catalano P., Malinow M. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol. 90:1997;168-171.
6. Powers R., Evans R., Majors A., Ojimba J., Ness R., Crombleholme W., et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with endothelial activation. Am J Obstet Gynecol. 179:1998;1605-1611.
7. Laivuori H., Kaaja R., Turpeinen U., Viinikka L., Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol. 93:1999;489-493.
8. Welch G., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 338:1998;1042-1050.
9. Malinow M., Rajkovic A., Duell P., Hess D., Upson B. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am J Obstet Gynecol. 178:1998;228-233.
10. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet. 34:1997;525-526.
11. Grandone E., Margaglione M., Colaizzo D., Cappucci G., Paladini D., Martinelli P., et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost. 77:1997;1052-1054.
12. O'Shaughnessy K., Fu B., Ferraro F., Lewis I., Downing S., Morris N. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension. 33:1999;1338-1341.
13. Powers R., Minich L., Lykins D., Ness R., Crombleholme W., Roberts J. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig. 6:1999;74-79.
14. Gifford R., August P., Chesley L., Cunningham G., Ferris T., Lindheimer M., et al. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 163:1990;1691-1712.
15. Vandenplas S., Wiid I., Globler-Rabie A., Brebner K., Ricketts M., Wallis G., et al. Blot hybridisation of genomic DNA. J Med Genet. 21:1984;164-172.
16. Norio R., Nevanlinna H., Perheentupa J. Hereditary diseases in Finland; rare flora in rare soil. Ann Clin Res. 5:1973;109-141.
17. Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR) Its frequency and impact on plasma homocysteine concentration in different European populations . Atherosclerosis. 136:1998;347-354.
18. Alfthan G., Pekkanen J., Jauhiainen M., Pitkäniemi J., Karvonen M., Tuomilehto J., et al. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19.
19. Pihkala J., Hakala T., Voutilainen P., Raivio K. Uudet suomalaiset sikiön kasvukäyrät [in Finnish]. Duodecim. 105:1989;1540-1546.